bck

Aducanumab Update

While various opinions are circulating, and the benefits of this drug are unclear, ANA will continue to monitor the situation and provide updates as information becomes available.

Dr. Klein featured in Neurology Today

Early on in their careers, two neurologists became involved in advocacy issues on behalf of neurology on a national, regional, and local level.